Cite
HARVARD Citation
Wortman, B. et al. (2018). Ten-year results of the PORTEC-2 trial for high-intermediate risk endometrial carcinoma: improving patient selection for adjuvant therapy. British journal of cancer. 119 (9), pp. 1067-1074. [Online].